Research connects stressful events with altered immune regulation, but the role of subjective stress is uncertain. Using a longitudinal design, we provide a statistically powerful test of the relationship between subjective stress (perceived stress, emotional distress) and immunity (T cell blastogenesis, natural killer cell cytotoxicity, [NKCC]) as individuals adjust to a severe stressor, a cancer diagnosis and its treatments. Women with regional breast cancer (N = 113) were assessed at diagnosis/surgery and reassessed 4, 8, 12, and 18 months later. Latent growth curve analysis tested two hypotheses: (1) initial levels of subjective stress will correlate inversely with initial levels of immunity, and (2) rate of change in subjective stress will correlate inversely with rate of change in immunity. As predicted by Hypothesis 1, participants with high initial subjective stress showed poor initial blastogenesis. As predicted by Hypothesis 2, participants exhibiting an early, rapid decline in subjective stress also showed rapid improvement in NKCC. Follow-up analyses revealed perceived stress to be strongly related to immune function, while emotional distress was not. This is the first study to investigate trajectories in stress and immunity during recovery from a major stressor. Results imply that NK and T cells are sensitive to different aspects of the stress response. While T cell blastogenesis correlated with initial (peak) subjective stress, NKCC correlated with change (improvement) in subjective stress. These data highlight the importance of subjective stress, particularly stress appraisals, in the immune response to a major stressor.
Introduction
More than two decades of research have established an association between psychological stressors and changes in immune function (Herbert and Cohen, 1993; Segerstrom and Miller, 2004) . This research body has overwhelmingly defined stress as the presence of a stressful event or circumstance, but a shift is now occurring. Rather than treating stressors as monotonic, there is a greater emphasis on studying individual variability in the stress response (see, for example, the 2003 special issue in Brain, Behavior and Immunity; e.g., Segerstrom, 2003) . Investigating individual variability has far-reaching implications, from elucidating the mechanisms by which psychological factors could affect immune function to understanding why stress reducing interventions may (or may not) affect immunity. The present study examines individual variability in subjective stress and immunity during adjustment to a severe stressor: a cancer diagnosis and treatment. 
